Position in AMGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$8,803,861
+$620,886 QoQ
Shares Held
24,312
+4.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
#597
of 3,140 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Canal Capital Management, LLC holds $33,454,879 across 10 Drug Manufacturers - General names. AMGN ranks #3 (26.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
46,715 | $11,864,208 | |
| 2 | LLY |
ELI LILLY & Co
|
7,938 | $9,521,076 | |
| 3 | AMGN |
Amgen Inc
This page
|
24,312 | $8,803,861 | |
| 4 | ABBV |
AbbVie Inc.
|
4,890 | $1,230,519 | |
| 5 | NVS |
Novartis AG
|
2,906 | $455,428 | |
| 6 | AZN |
Astrazeneca PLC
|
1,927 | $365,397 | |
| 7 | GSK |
GSK plc
|
6,800 | $356,456 | |
| 8 | NVO |
Novo Nordisk A S
|
6,524 | $312,760 |
All Filings in AMGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,803,861 | 24,312 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $8,182,975 | 23,257 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $7,516,674 | 22,965 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $6,307,734 | 22,352 | Shares | Sole | 2026-01-06 | |
| 2025-06-30 | $6,038,753 | 21,628 | Shares | Sole | 2025-09-19 | |
| 2025-03-31 | $6,314,806 | 20,269 | Shares | Sole | 2025-09-19 | |
| No filing history on record for this holder in this stock. | ||||||